hematopoietic stem cells gene therapy (Cellectis)

N/A

Report date: 2025/01/26 18:00:11

Base Information

Drug Namehematopoietic stem cells gene therapy (Cellectis)
Drug Alias Nameex vivo autologous hematopoietic stem cell therapy (Cellectis)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionAlpha-L-iduronidase stimulants
TargetsAlpha-L-iduronidase
Therapy Area/IndicationsMetabolic DiseasesLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellectis Sa
China Registration ClassN/A

Develop Information

Active CompaniesCellectis Sa
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesLysosomal Storage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A